Renata PLC is a pharmaceutical company primarily involved in the manufacture and marketing of human pharmaceuticals and animal therapeutics. With three manufacturing sites, the company has a long history, starting its operations as Pfizer (Bangladesh) Limited in 1972. Following Pfizer's shift in focus from formulations to research in the late 1990s, it divested its interests in various countries, including Bangladesh. In 1993, the ownership of its Bangladesh operations was transferred to local shareholders, and Renata Limited was born. In a significant move, Pfizer donated shares to the SAJIDA Foundation, resulting in the foundation holding a 51% ownership in Renata Limited, in addition to a partial payment. The SAJIDA Foundation's microfinance and micro-insurance programs have been instrumental in supporting a large number of members and their families, with cumulative loan disbursements totalling BDT 5,750 million. Notably, the foundation's health program currently benefits over 1 million beneficiaries through various avenues such as hospitals, panel doctors, and mobile health teams. Presently, the SAJIDA Foundation maintains majority ownership in Renata Limited, showcasing the company's commitment to socially responsible partnerships. For further information on the SAJIDA Foundation's initiatives and Renata Limited, interested parties are encouraged to visit the foundation’s website at www.sajidafoundation.org. Renata PLC operates within the health care, manufacturing, and pharmaceutical industries, positioning itself as a key player in these sectors.
There is no investment information
No recent news or press coverage available for Renata PLC.